Most Read Articles
03 Sep 2018
Dietary nicotinamide riboside (NR) supplementation in 2,000-mg doses daily over a 12-week period is safe, a recent study has shown. However, it does not improve insulin sensitivity and whole-body glucose metabolism in obese, insulin-resistant men.
16 May 2016
Levothyroxine is linked with reduced risk of low birth weight and low Apgar score in pregnant women with subclinical hypothyroidism, a study reported.
02 Jul 2018
Consumption of non-nutritive sweeteners does not appear to contribute to an increase in blood glucose level, a study reports.
13 Apr 2016
Levothyroxine restores reduced circulating fibroblast growth factor 21 (FGF21) levels in overt hypothyroidism patients, as indicated in a study.

Smoking cessation improves survival in diabetics

11 Apr 2018

Quitting smoking following diabetes diagnosis appears to significantly cut mortality risk, particularly when paired with proper weight management, a recent Korea study has shown.

Researchers recruited 17,204 males (median age 52 years) who were newly diagnosed with type 2 diabetes and free from stroke or myocardial infarction. Survival regression analysis was performed to determine the risk of all-cause and cardiovascular diseases.

Multivariate adjusted analysis showed that men who quit smoking but showed no changes in body mass index (BMI) had a significantly lower risk of all-cause mortality compared with sustained smokers (adjusted hazard ratio [HR], 0.68; 95 percent CI, 0.46–1.00; p=0.05).

Men who quit smoking but gained BMI also showed a reduced risk of all-cause mortality, but the effect was not statistically significant (adjusted HR, 0.67; 0.36–1.24; p=0.21). Interestingly, smoking cessation coupled with BMI loss resulted in a significant increase in the risk of mortality (adjusted HR, 1.76; 1.13–2.73; p=0.01).

None of the patient groups were associated with significant changes in the risk of cardiovascular diseases. However, smoking cessation with BMI loss was associated with a nominal increase in the risk (adjusted HR, 1.09; 0.71–1.68; p=0.71), while cessation with BMI gain led to a marginal drop in the risk (adjusted HR, 0.94; 0.60–1.47; p=0.79).

The findings of the present study suggest that physicians should inform newly-diagnosed type 2 diabetes patients about the potential survival benefits of smoking cessation, as well weight management strategies that may help maximize the said benefits, according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
03 Sep 2018
Dietary nicotinamide riboside (NR) supplementation in 2,000-mg doses daily over a 12-week period is safe, a recent study has shown. However, it does not improve insulin sensitivity and whole-body glucose metabolism in obese, insulin-resistant men.
16 May 2016
Levothyroxine is linked with reduced risk of low birth weight and low Apgar score in pregnant women with subclinical hypothyroidism, a study reported.
02 Jul 2018
Consumption of non-nutritive sweeteners does not appear to contribute to an increase in blood glucose level, a study reports.
13 Apr 2016
Levothyroxine restores reduced circulating fibroblast growth factor 21 (FGF21) levels in overt hypothyroidism patients, as indicated in a study.